Symbols / POM $0.32 -26.69%
POM Chart
About
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Pharmaceutical Retailers | Market Cap | 38.14M |
| Enterprise Value | 2.27B | Income | -148.90M | Sales | 366.86M |
| Book/sh | -8.93 | Cash/sh | 0.91 | Dividend Yield | — |
| Payout | 0.00% | Employees | 156 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.10 | P/B | -0.04 | P/C | — |
| EV/EBITDA | -87.42 | EV/Sales | 6.18 | Quick Ratio | 0.09 |
| Current Ratio | 0.17 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.05 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 16.20% | Earnings | — | ROA | -32.56% |
| ROE | — | ROIC | — | Gross Margin | 14.08% |
| Oper. Margin | -6.54% | Profit Margin | -40.59% | Shs Outstand | 106.94M |
| Shs Float | 2.48M | Short Float | — | Short Ratio | 0.46 |
| Short Interest | — | 52W High | 6.43 | 52W Low | 0.19 |
| Beta | — | Avg Volume | 804.70K | Volume | 680.82K |
| Target Price | — | Recom | None | Prev Close | $0.44 |
| Price | $0.32 | Change | -26.69% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
News
RSS: Latest POM news- POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Morningstar ue, 10 Mar 2026 18
- Should You Buy POM Stock After the PomDoctor IPO? - Yahoo Finance Fri, 10 Oct 2025 07
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM - ChartMill ue, 10 Mar 2026 19
- 12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga ue, 10 Mar 2026 17
- Shareholders who lost money in American Depositary Receipts - GlobeNewswire ue, 10 Mar 2026 14
- Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against POMDOCTOR LIMITED (POM), BlackRock TCP Capital Corp. (TCPC), and Paysafe Limited (PSFE) Announced by Holzer & Holzer, LLC - marketscreener.com Mon, 09 Mar 2026 12
- POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor Investors of Securities Class Action Deadline on April 13, 2026 - The Malaysian Reserve Fri, 06 Mar 2026 08
- Is POM’s Stock the Next Big Bet? - StocksToTrade Wed, 10 Dec 2025 08
- Pomdoctor closes $20M IPO to grow mobile health platform in China - BioWorld MedTech Fri, 10 Oct 2025 07
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga ue, 10 Mar 2026 12
- POM Class Action: POMDoctor Ltd. Stockholders with Large - GlobeNewswire hu, 05 Mar 2026 19
- POM Stock Surges Amid Expansive Market Moves - StocksToTrade Fri, 05 Dec 2025 08
- 12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga Mon, 09 Mar 2026 21
- POM’s Stock Surges Amid Improved Market Outlook - StocksToTrade Wed, 03 Dec 2025 08
- Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - simplywall.st Fri, 05 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -22.03M | -21.38M | -3.81M | -33.63M |
| TotalUnusualItems | -2.24M | -1.61M | 0.00 | -24.94M |
| TotalUnusualItemsExcludingGoodwill | -2.24M | -1.61M | 0.00 | -24.94M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -37.39M | -36.95M | -19.83M | -96.17M |
| ReconciledDepreciation | 134.51K | 112.09K | 0.00 | 21.32M |
| ReconciledCostOfRevenue | 294.86M | 266.13M | 190.36M | 162.88M |
| EBITDA | -24.27M | -22.99M | -3.81M | -58.58M |
| EBIT | -24.40M | -23.10M | -3.81M | -79.89M |
| NetInterestIncome | -12.96M | -13.85M | -16.02M | -16.29M |
| InterestExpense | 12.96M | 13.85M | 16.02M | 16.29M |
| NormalizedIncome | -35.15M | -35.34M | -19.83M | -71.23M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -37.39M | -36.95M | -19.83M | -96.17M |
| TotalExpenses | 365.92M | 325.17M | 248.53M | 269.93M |
| TotalOperatingIncomeAsReported | -25.79M | -22.25M | -3.59M | -79.67M |
| DilutedAverageShares | 118.44M | 118.44M | 118.44M | |
| BasicAverageShares | 118.44M | 118.44M | 118.44M | |
| DilutedEPS | -1.23 | -1.06 | -1.59 | |
| BasicEPS | -1.23 | -1.06 | -1.59 | |
| DilutedNIAvailtoComStockholders | -143.36M | -145.39M | -125.51M | -188.40M |
| NetIncomeCommonStockholders | -143.36M | -145.39M | -125.51M | -188.40M |
| NetIncome | -143.36M | -145.39M | -125.51M | -188.40M |
| MinorityInterests | -25.88K | -1.06K | 1.88K | 15.27K |
| NetIncomeIncludingNoncontrollingInterests | -143.34M | -145.39M | -125.51M | -188.42M |
| NetIncomeFromTaxLossCarryforward | -105.97M | -108.44M | -105.68M | -92.24M |
| NetIncomeContinuousOperations | -37.37M | -36.95M | -19.83M | -96.18M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -37.37M | -36.95M | -19.83M | -96.18M |
| OtherIncomeExpense | -1.04M | -2.78M | -494.54K | -25.34M |
| OtherNonOperatingIncomeExpenses | 1.20M | -1.17M | -494.54K | -403.96K |
| SpecialIncomeCharges | -2.24M | -1.61M | 0.00 | -24.94M |
| WriteOff | 0.00 | 500.00K | 0.00 | |
| ImpairmentOfCapitalAssets | 2.24M | 1.11M | 0.00 | 24.94M |
| NetNonOperatingInterestIncomeExpense | -12.96M | -13.85M | -16.02M | -16.29M |
| InterestExpenseNonOperating | 12.96M | 13.85M | 16.02M | 16.29M |
| OperatingIncome | -23.36M | -20.32M | -3.31M | -54.55M |
| OperatingExpense | 71.06M | 59.04M | 58.18M | 107.05M |
| OtherOperatingExpenses | -189.50K | -321.57K | -280.16K | -180.50K |
| ResearchAndDevelopment | 3.00M | 3.37M | 3.59M | 4.28M |
| SellingGeneralAndAdministration | 68.24M | 55.99M | 54.87M | 102.95M |
| SellingAndMarketingExpense | 56.37M | 43.68M | 47.46M | 84.10M |
| GeneralAndAdministrativeExpense | 11.88M | 12.31M | 7.41M | 18.85M |
| OtherGandA | 11.88M | 12.31M | 7.41M | 18.85M |
| GrossProfit | 47.69M | 38.72M | 54.86M | 52.51M |
| CostOfRevenue | 294.86M | 266.13M | 190.36M | 162.88M |
| TotalRevenue | 342.56M | 304.85M | 245.22M | 215.38M |
| OperatingRevenue | 342.56M | 304.85M | 245.22M | 215.38M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 19.74M | 19.74M | 19.74M | 19.74M |
| ShareIssued | 19.74M | 19.74M | 19.74M | 19.74M |
| NetDebt | 430.39M | 404.09M | 345.89M | 333.71M |
| TotalDebt | 441.10M | 413.29M | 361.24M | 341.26M |
| TangibleBookValue | -2.26B | -2.12B | -1.97B | -1.85B |
| InvestedCapital | -1.83B | -1.71B | -1.63B | -1.51B |
| WorkingCapital | -141.65M | -112.58M | -95.87M | -90.96M |
| NetTangibleAssets | -2.26B | -2.12B | -1.97B | -1.85B |
| CapitalLeaseObligations | 3.06M | 2.48M | 12.87M | 5.38M |
| CommonStockEquity | -2.26B | -2.12B | -1.97B | -1.85B |
| TotalCapitalization | -1.90B | -1.76B | -1.66B | -1.54B |
| TotalEquityGrossMinorityInterest | -2.09B | -1.96B | -1.90B | -1.78B |
| MinorityInterest | 168.69M | 158.64M | 76.66M | 71.66M |
| StockholdersEquity | -2.26B | -2.12B | -1.97B | -1.85B |
| OtherEquityInterest | -1.61K | -1.61K | ||
| GainsLossesNotAffectingRetainedEarnings | -5.23K | 0.00 | ||
| OtherEquityAdjustments | -5.23K | |||
| RetainedEarnings | -2.26B | -2.12B | -1.97B | -1.85B |
| CapitalStock | 4.40K | 4.40K | 2.79K | 2.79K |
| CommonStock | 4.40K | 4.40K | 2.79K | 2.79K |
| TotalLiabilitiesNetMinorityInterest | 2.14B | 2.03B | 1.95B | 1.80B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.96B | 1.86B | 1.80B | 1.69B |
| PreferredSecuritiesOutsideStockEquity | 1.60B | 1.50B | 1.47B | 1.37B |
| LongTermDebtAndCapitalLeaseObligation | 366.76M | 356.62M | 330.37M | 315.45M |
| LongTermCapitalLeaseObligation | 1.67M | 1.22M | 11.44M | 2.94M |
| LongTermDebt | 365.09M | 355.40M | 318.93M | 312.51M |
| CurrentLiabilities | 179.15M | 172.00M | 143.61M | 109.39M |
| OtherCurrentLiabilities | 2.08M | |||
| CurrentDeferredLiabilities | 1.76M | 1.24M | 2.73M | 1.46M |
| CurrentDeferredRevenue | 1.76M | 1.24M | 2.73M | 1.46M |
| CurrentDebtAndCapitalLeaseObligation | 74.34M | 56.67M | 30.87M | 25.81M |
| CurrentCapitalLeaseObligation | 1.39M | 1.27M | 1.42M | 2.43M |
| CurrentDebt | 72.95M | 55.41M | 29.45M | 23.38M |
| OtherCurrentBorrowings | 37.99M | 33.41M | 19.40M | 21.79M |
| LineOfCredit | 34.96M | 22.00M | 10.04M | 1.58M |
| PayablesAndAccruedExpenses | 100.97M | 114.08M | 110.00M | 82.13M |
| CurrentAccruedExpenses | 46.46M | 47.84M | 38.67M | 9.43M |
| InterestPayable | 36.75M | 38.04M | 28.78M | |
| Payables | 54.51M | 66.24M | 71.33M | 72.70M |
| OtherPayable | 28.26M | 23.04M | 25.97M | 23.12M |
| DuetoRelatedPartiesCurrent | 80.04K | 1.30M | 1.68M | 18.81M |
| TotalTaxPayable | 815.46K | 213.81K | 329.18K | 361.45K |
| AccountsPayable | 25.35M | 41.69M | 43.35M | 30.41M |
| TotalAssets | 46.23M | 66.31M | 48.62M | 19.31M |
| TotalNonCurrentAssets | 8.73M | 6.89M | 877.63K | 877.63K |
| OtherNonCurrentAssets | 831.13K | 549.50K | 377.63K | 377.63K |
| NonCurrentDeferredAssets | 7.44M | 5.74M | 0.00 | |
| InvestmentsAndAdvances | 0.00 | 500.00K | 500.00K | |
| NetPPE | 461.36K | 595.87K | 0.00 | |
| AccumulatedDepreciation | -10.82M | -10.69M | -10.71M | |
| GrossPPE | 11.28M | 11.29M | 10.71M | |
| Leases | 4.76M | 4.76M | 4.85M | |
| MachineryFurnitureEquipment | 6.52M | 6.53M | 5.86M | |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 37.50M | 59.42M | 47.74M | 18.43M |
| RestrictedCash | 0.00 | 88.07K | 159.90K | 0.00 |
| PrepaidAssets | 5.71M | 7.53M | 9.65M | 7.41M |
| Inventory | 9.17M | 12.69M | 8.20M | 8.12M |
| InventoriesAdjustmentsAllowances | -494.46K | -503.08K | ||
| FinishedGoods | 9.66M | 13.20M | 8.20M | |
| Receivables | 14.97M | 32.39M | 27.25M | 739.57K |
| ReceivablesAdjustmentsAllowances | -2.68M | -1.98M | -1.45M | -2.22M |
| OtherReceivables | 538.14K | 463.81K | 426.58K | 784.61K |
| DuefromRelatedPartiesCurrent | 5.63M | 2.40M | ||
| TaxesReceivable | 2.68M | 2.86M | 0.00 | |
| AccountsReceivable | 8.80M | 28.64M | 28.27M | 2.18M |
| AllowanceForDoubtfulAccountsReceivable | -806.35K | -846.68K | 0.00 | 0.00 |
| GrossAccountsReceivable | 9.61M | 29.49M | 28.27M | 2.18M |
| CashCashEquivalentsAndShortTermInvestments | 7.65M | 6.72M | 2.49M | 2.17M |
| CashAndCashEquivalents | 7.65M | 6.72M | 2.49M | 2.17M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -16.17M | -45.91M | -22.02M | -15.68M |
| RepaymentOfDebt | -68.24M | -84.21M | -12.94M | -57.99M |
| IssuanceOfDebt | 85.26M | 136.55M | 35.43M | 63.42M |
| CapitalExpenditure | -37.77K | -111.89K | ||
| InterestPaidSupplementalData | 2.74M | 2.39M | 3.24M | 4.05M |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | |
| EndCashPosition | 7.65M | 6.81M | 2.65M | 2.17M |
| BeginningCashPosition | 6.81M | 2.65M | 2.17M | 12.92M |
| EffectOfExchangeRateChanges | -5.23K | 0.00 | ||
| ChangesInCash | 851.83K | 4.16M | 474.66K | -10.74M |
| FinancingCashFlow | 17.02M | 50.07M | 22.49M | 5.44M |
| CashFlowFromContinuingFinancingActivities | 17.02M | 50.07M | 22.49M | 5.44M |
| NetOtherFinancingCharges | -2.28M | |||
| NetIssuancePaymentsOfDebt | 17.02M | 52.34M | 22.49M | 5.44M |
| NetShortTermDebtIssuance | 12.96M | 12.34M | 8.57M | -8.58M |
| ShortTermDebtPayments | -31.14M | -15.66M | -1.52M | -25.06M |
| ShortTermDebtIssuance | 44.10M | 28.00M | 10.10M | 16.48M |
| NetLongTermDebtIssuance | 4.06M | 40.01M | 13.92M | 14.02M |
| LongTermDebtPayments | -37.10M | -68.55M | -11.41M | -32.92M |
| LongTermDebtIssuance | 41.16M | 108.55M | 25.33M | 46.94M |
| InvestingCashFlow | -33.37K | -111.89K | 0.00 | -500.00K |
| CashFlowFromContinuingInvestingActivities | -33.37K | -111.89K | 0.00 | -500.00K |
| NetInvestmentPurchaseAndSale | 0.00 | -500.00K | ||
| PurchaseOfInvestment | 0.00 | -500.00K | ||
| NetPPEPurchaseAndSale | -33.37K | -111.89K | 0.00 | 0.00 |
| SaleOfPPE | 4.40K | 0.00 | 0.00 | 0.00 |
| PurchaseOfPPE | -37.77K | -111.89K | 0.00 | |
| OperatingCashFlow | -16.13M | -45.80M | -22.02M | -15.68M |
| CashFlowFromContinuingOperatingActivities | -16.13M | -45.80M | -22.02M | -15.68M |
| ChangeInWorkingCapital | 17.53M | -12.56M | -1.41M | 35.14M |
| ChangeInOtherWorkingCapital | 512.62K | -1.49M | 1.28M | 1.45M |
| ChangeInOtherCurrentLiabilities | 1.00M | -1.99M | -2.51M | -3.43M |
| ChangeInOtherCurrentAssets | -281.63K | -171.87K | 0.00 | 925.59K |
| ChangeInPayablesAndAccruedExpense | -5.14M | 607.86K | 27.88M | 39.35M |
| ChangeInAccruedExpense | -82.39K | -96.45K | 461.68K | -362.68K |
| ChangeInPayable | -5.05M | 704.31K | 27.42M | 39.71M |
| ChangeInAccountPayable | -16.34M | -1.66M | 12.94M | 5.43M |
| ChangeInTaxPayable | 601.15K | -115.37K | -32.27K | -991.78K |
| ChangeInIncomeTaxPayable | 601.15K | -115.37K | -32.27K | -991.78K |
| ChangeInPrepaidAssets | 1.95M | -53.70K | -1.23M | -635.72K |
| ChangeInInventory | 3.03M | -5.00M | -77.56K | -1.59M |
| ChangeInReceivables | 16.45M | -4.45M | -26.75M | -917.34K |
| ChangesInAccountReceivables | 19.89M | -1.27M | -26.10M | -1.76M |
| ProvisionandWriteOffofAssets | 1.34M | 1.99M | -774.45K | -894.77K |
| AssetImpairmentCharge | 2.24M | 1.61M | 0.00 | 24.94M |
| DepreciationAmortizationDepletion | 134.51K | 112.09K | 0.00 | 21.32M |
| DepreciationAndAmortization | 134.51K | 112.09K | 0.00 | 21.32M |
| AmortizationCashFlow | 0.00 | 17.34M | ||
| AmortizationOfIntangibles | 0.00 | 17.34M | ||
| Depreciation | 134.51K | 112.09K | 0.00 | 3.98M |
| OperatingGainsLosses | -3.89K | |||
| GainLossOnSaleOfPPE | -3.89K | 0.00 | ||
| NetIncomeFromContinuingOperations | -37.37M | -36.95M | -19.83M | -96.18M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for POM
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|